Friday, October 07, 2022 4:43:22 PM
By all appearances it’s a done deal ex. Manufacturing for approval is all that’s left
I am a very serious long, but what scares me at times is why the rest of the market does not see that as well. Even just a small portion of the market would be enough for the price to be at normal levels. This is just not normal for a bio just prior to approval after a lengthy pIII trial that is well known to those in the industry. Especially for one that could be revolutionary and the first real treatment for rGBM and nGBM and the start of a major cancer platform. There is absolutely no buying pressure at all. Those old longs have a full basket - but virtually no long buyers. The MMs should not have the playing field all to themselves. Even when the ask is 67.9999 with a mere 1000 shares on the ask, there are no buyers to push it over the 68 mark (except at the close by mere pennies). this does worry me - and LP should understand the worries of her investors and relieve them to the extent she can, Why is there no active market in this stock. (actually my previous question is the answer to my last - because LP does not give her investors any info, even when she certainly could,) I think there is more to lose than there is to gain by LP policy of silence rather than the normal but prudent flow of information to investors..
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
